Beall has been studying the human response to hypoxic living conditions for years. In research published in October 2024, she and her team unveiled some of the specific adaptations in Tibetan ...
Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined ...